Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2018-06-27 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHOLET (49300), Maine-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE VAL DE MOINE : revenue, balance sheet and financial ratios
PHARMACIE VAL DE MOINE is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHOLET (49300),
this company of category PME
shows in 2025 a net income positive of 174 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE VAL DE MOINE (SIREN 840691083)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
174 467 €
289 264 €
209 481 €
183 236 €
183 110 €
180 491 €
105 190 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE VAL DE MOINE generates positive net income of 174 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 105 k€ -> 174 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
174 467 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 103%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
103.207%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
38.681%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE VAL DE MOINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1547.428
678.008
438.187
291.221
199.494
104.526
103.207
Financial autonomy
5.173
11.0
16.484
22.597
29.107
41.314
38.681
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
103.212025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-8 pts over 3 years
In 2025, the debt ratio of PHARMACIE VAL DE MOINE (103.21) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
38.68%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+6 pts over 3 years
In 2025, the financial autonomy of PHARMACIE VAL DE MOINE (38.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 111.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
111.85
Liquidity indicators evolution PHARMACIE VAL DE MOINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
144.19
136.488
171.723
172.91
170.37
109.533
111.85
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
111.852025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-20 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE VAL DE MOINE (111.85) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE VAL DE MOINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE VAL DE MOINE is estimated at
2 771 429 €
(range 1 880 704€ - 4 348 753€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1880k€2771k€4348k€
2 771 429 €Range: 1 880 704€ - 4 348 753€
NAF 5 année 2025
Valuation method used
Net Income Multiple
174 467 €
×
15.9x
=2 771 429 €
Range: 1 880 705€ - 4 348 754€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE VAL DE MOINE with other companies in the same sector:
Frequently asked questions about PHARMACIE VAL DE MOINE
What is the revenue of PHARMACIE VAL DE MOINE ?
The revenue of PHARMACIE VAL DE MOINE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE VAL DE MOINE profitable?
Yes, PHARMACIE VAL DE MOINE generated a net profit of 174 k€ in 2025.
Where is the headquarters of PHARMACIE VAL DE MOINE ?
The headquarters of PHARMACIE VAL DE MOINE is located in CHOLET (49300), in the department Maine-et-Loire.
Where to find the tax return of PHARMACIE VAL DE MOINE ?
The tax return of PHARMACIE VAL DE MOINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE VAL DE MOINE operate?
PHARMACIE VAL DE MOINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart